---
title: "3D Medicines Appoints Chief Commercial Officer"
date: "2025-02-11 10:39:14"
summary: "3D Medicines appointed Ding Gan as the chief commercial officer, according to a Monday filing with the Hong Kong bourse. Ding has more than 30 years of experience in the pharmaceutical and biotechnology industries, the filing added. He most recently served as served as the chief executive officer of Nicoya..."
categories:
  - "MT Newswires"
lang:
  - "en"
translations:
  - "en"
tags:
  - "MT Newswires"
menu: ""
thumbnail: ""
lead: ""
comments: false
authorbox: false
pager: true
toc: false
mathjax: false
sidebar: "right"
widgets:
  - "search"
  - "recent"
  - "taglist"
---

3D Medicines appointed Ding Gan as the chief commercial officer, according to a Monday filing with the Hong Kong bourse.

Ding has more than 30 years of experience in the pharmaceutical and biotechnology industries, the filing added. He most recently served as served as the chief executive officer of Nicoya Therapeutics

(Shanghai) and Alternative Bio (ABio).

[MT Newswires](https://www.tradingview.com/news/mtnewswires.com:20250210:G2465947:0/)
